Literature DB >> 12444353

Risk for delirium tremens in patients with alcohol withdrawal syndrome.

David A Fiellin1, Patrick G O'Connor, Eric S Holmboe, Ralph I Horwitz.   

Abstract

To determine the characteristics associated with an increased risk for delirium tremens (DT) we performed a case-control study at the detoxification units of two hospitals. Cases met DSM-IV criteria for DT. For each case (n = 15), 3 controls (n = 45) were chosen. Eligibility criteria were applied equally to cases and controls. Cases were more likely than controls to report a prior complicated withdrawal (DT or alcohol withdrawal seizure) (53 vs. 27%, OR 3.1, 95% CI 0.94-10.55), have a systolic blood pressure greater than 145 mm Hg on admission (60 vs. 27%, OR 4.1, 95% CI 1.21-14.06), and have comorbidity scores of at least 1 (60 vs. 18%, OR 6.9, 95% CI 1.92-25.08). Zero cases (0%) and 15 (33%) controls had no prior complicated withdrawals and no adverse clinical features (systolic blood pressure >145 or comorbidity score >1). Compared to this group, the odds of being a case and having both prior complicated withdrawal and at least 1 adverse clinical feature was 44.8 (95% CI 4.36-460). Elevated blood pressure, prior complicated alcohol withdrawal and medical comorbidity, alone and in combination, are associated with an increased risk of delirium tremens.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12444353     DOI: 10.1080/08897070209511478

Source DB:  PubMed          Journal:  Subst Abus        ISSN: 0889-7077            Impact factor:   3.716


  7 in total

Review 1.  Baclofen for alcohol withdrawal.

Authors:  Jia Liu; Lu-Ning Wang
Journal:  Cochrane Database Syst Rev       Date:  2017-08-20

2.  Comparative efficacy of baclofen and lorazepam in the treatment of alcohol withdrawal syndrome.

Authors:  Prannay Gulati; Bir Singh Chavan; Ajeet Sidana
Journal:  Indian J Psychiatry       Date:  2019 Jan-Feb       Impact factor: 1.759

Review 3.  GABAB Receptors and Alcohol Use Disorders: Clinical Studies.

Authors:  Warren B Logge; Kirsten C Morley; Paul S Haber
Journal:  Curr Top Behav Neurosci       Date:  2022

4.  Risk factors for the development of delirium in alcohol dependence syndrome: Clinical and neurobiological implications.

Authors:  Sukanto Sarkar; Sunayana Choudhury; Gem Ezhumalai; Janet Konthoujam
Journal:  Indian J Psychiatry       Date:  2017 Jul-Sep       Impact factor: 1.759

5.  A standardized polyherbal preparation POL-6 diminishes alcohol withdrawal anxiety by regulating Gabra1, Gabra2, Gabra3, Gabra4, Gabra5 gene expression of GABAA receptor signaling pathway in rats.

Authors:  Lalit Sharma; Aditi Sharma; Ashutosh Kumar Dash; Gopal Singh Bisht; Girdhari Lal Gupta
Journal:  BMC Complement Med Ther       Date:  2021-01-06

Review 6.  Emerging concepts in alcoholic hepatitis.

Authors:  Phoenix Fung; Nikolaos Pyrsopoulos
Journal:  World J Hepatol       Date:  2017-04-28

7.  Research Needs for Inpatient Management of Severe Alcohol Withdrawal Syndrome: An Official American Thoracic Society Research Statement.

Authors:  Tessa L Steel; Majid Afshar; Scott Edwards; Sarah E Jolley; Christine Timko; Brendan J Clark; Ivor S Douglas; Amy L Dzierba; Hayley B Gershengorn; Nicholas W Gilpin; Dwayne W Godwin; Catherine L Hough; José R Maldonado; Anuj B Mehta; Lewis S Nelson; Mayur B Patel; Darius A Rastegar; Joanna L Stollings; Boris Tabakoff; Judith A Tate; Adrian Wong; Ellen L Burnham
Journal:  Am J Respir Crit Care Med       Date:  2021-10-01       Impact factor: 21.405

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.